Found 33 results
Type [ Year(Asc)]
D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, A Gardner, RM Zhang, T Esfandiary, J L'Heureux et al. "Computationally guided high-throughput design of self-assembling drug nanoparticles." Nature Nanotechnology (2021).
D Reker, EA Hoyt, GJL Bernardes, and T Rodrigues. "Adaptive Optimization of Chemical Reactions with Minimal Experimental Information." Cell Reports Physical Science 1, no. 11 (2020).
N Brown, P Ertl, R Lewis, T Luksch, D Reker, and N Schneider. "Artificial intelligence in chemistry and drug design." Journal of Computer Aided Molecular Design 34, no. 7 (2020): 709-715.
D Reker, SM Blum, P Wade, C Steiger, and G Traverso. "Historical Evolution and Provider Awareness of Inactive Ingredients in Oral Medications." Pharm Res 37, no. 12 (2020).
D Reker, Y Shi, AR Kirtane, K Hess, GJ Zhong, E Crane, C-H Lin, R Langer, and G Traverso. "Machine Learning Uncovers Food- and Excipient-Drug Interactions." Cell Reports 30, no. 11 (2020): 3710-3716.e4.
T von Erlach, S Saxton, Y Shi, D Minahan, D Reker, F Javid, Y-AL Lee, C Schoellhammer, T Esfandiary, C Cleveland et al. "Robotically handled whole-tissue culture system for the screening of oral drug formulations." Nature Biomedical Engineering 4, no. 5 (2020): 544-559.
D Reker, and RA Lewis. "Advanced Editorial to announce a JCAMD Special Issue on Artificial Intelligence and Machine Learning." Journal of Computer Aided Molecular Design 33, no. 11 (2019).
D Reker, GJL Bernardes, and T Rodrigues. "Computational advances in combating colloidal aggregation in drug discovery." Nature Chemistry 11, no. 5 (2019): 402-418.
D Reker, SM Blum, C Steiger, KE Anger, JM Sommer, J Fanikos, and G Traverso. ""Inactive" ingredients in oral medications." Science Translational Medicine 11, no. 483 (2019).
D Reker. "Practical considerations for active machine learning in drug discovery." Drug Discovery Today: Technologies 32-33 (2019): 73-79.
L Li, CC Koh, D Reker, JB Brown, H Wang, NK Lee, H-H Liow, H Dai, H-M Fan, L Chen et al. "Predicting protein-ligand interactions based on bow-pharmacological space and Bayesian additive regression trees." Scientific Reports 9, no. 1 (2019).
D Reker, P Schneider, G Schneider, and JB Brown. "Active learning for computational chemogenomics." Future Medicinal Chemistry 9, no. 4 (2017): 381-402.
F Grisoni, D Reker, P Schneider, L Friedrich, V Consonni, R Todeschini, A Koeberle, O Werz, and G Schneider. "Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening." Molecular Informatics 36, no. 1-2 (2017).
J Cui, M Hollmén, L Li, Y Chen, ST Proulx, D Reker, G Schneider, and M Detmar. "New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate." Oncotarget 8, no. 1 (2017): 1007-1022.
T Rodrigues, D Reker, P Schneider, and G Schneider. "Counting on natural products for drug design." Nature Chemistry 8, no. 6 (2016): 531-541.
G Schneider, D Reker, T Chen, K Hauenstein, P Schneider, and K-H Altmann. "Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide." Angewandte Chemie International Edition 55, no. 40 (2016): 12408-12411.
D Reker, P Schneider, and G Schneider. "Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors." Chem. Sci. 7, no. 6 (2016): 3919-3927.
P Schneider, M Röthlisberger, D Reker, and G Schneider. "Spotting and designing promiscuous ligands for drug discovery." Chemical Communications 52, no. 6 (2016): 1135-1138.
D Reker, and G Schneider. "Active-learning strategies in computer-assisted drug discovery." Drug Discovery Today 20, no. 4 (2015): 458-465.
T Miyao, D Reker, P Schneider, K Funatsu, and G Schneider. "Chemography of natural product space." Planta Medica 81, no. 6 (2015): 429-435.
T Rodrigues, D Reker, M Welin, M Caldera, C Brunner, G Gabernet, P Schneider, B Walse, and G Schneider. "De Novo Fragment Design for Drug Discovery and Chemical Biology." Angewandte Chemie International Edition 54, no. 50 (2015): 15079-15083.
AM Perna, T Rodrigues, TP Schmidt, M Böhm, K Stutz, D Reker, B Pfeiffer, K-H Altmann, S Backert, S Wessler et al. "Fragment-Based De Novo Design Reveals a Small-Molecule Inhibitor of Helicobacter Pylori HtrA." Angewandte Chemie International Edition 54, no. 35 (2015): 10244-10248.
T Rodrigues, N Hauser, D Reker, M Reutlinger, T Wunderlin, J Hamon, G Koch, and G Schneider. "Multidimensional de novo design reveals 5-HT2B receptor-selective ligands." Angewandte Chemie International Edition 54, no. 5 (2015): 1551-1555.
T Rodrigues, D Reker, J Kunze, P Schneider, and G Schneider. "Revealing the Macromolecular Targets of Fragment-Like Natural Products." Angewandte Chemie International Edition 54, no. 36 (2015): 10516-10520.
G Schneider, D Reker, T Rodrigues, and P Schneider. "Coping with polypharmacology by computational medicinal chemistry." Chimia International Journal for Chemistry 68, no. 9 (2014): 648-653.